4//SEC Filing
HIGH SUSANNA GATTI 4
Accession 0000950170-24-108154
CIK 0001818794other
Filed
Sep 18, 8:00 PM ET
Accepted
Sep 19, 4:52 PM ET
Size
7.2 KB
Accession
0000950170-24-108154
Insider Transaction Report
Form 4
HIGH SUSANNA GATTI
Chief Operating Officer
Transactions
- Sale
Common Stock
2024-09-18$34.41/sh−4,636$159,525→ 131,636 total - Sale
Common Stock
2024-09-18$34.41/sh−4,340$149,339→ 136,272 total
Footnotes (4)
- [F1]Represents shares automatically sold by the Reporting Person to satisfy tax withholding obligations in connection with the vesting of restricted stock units granted to the Reporting Person on September 17, 2020. The automatic sale of the Reporting Person's shares is provided for in a restricted stock unit agreement constituting a "binding contract" consistent with the affirmative defense to liability under Rule 10b5-1 and the sale does not represent a discretionary trade by the Reporting Person.
- [F2]The price reported in Column 4 is a weighted average price. These shares were sold in multiple transactions at prices within the range of $34.09 to $34.70, inclusive. The Reporting Person undertakes to provide to the Issuer, any security holder of the Issuer or the staff of the Securities and Exchange Commission, upon request, full information regarding the number of shares sold at each separate price within the range set forth in this footnote of this Form 4.
- [F3]Includes 114,453 unvested RSUs.
- [F4]The sales reported in this Form 4 were effected pursuant to a Rule 10b5-1 trading plan adopted by the Reporting Person on March 11, 2024.
Documents
Issuer
Dyne Therapeutics, Inc.
CIK 0001818794
Entity typeother
Related Parties
1- filerCIK 0001691005
Filing Metadata
- Form type
- 4
- Filed
- Sep 18, 8:00 PM ET
- Accepted
- Sep 19, 4:52 PM ET
- Size
- 7.2 KB